REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/17/2025
Back to search
Official data from USPTO
XSPIRE PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
XSPIRE PHARMA
ST13
US500000088659985Class
5
Filing
88659985
Registration
6198359
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
11/18/2025
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
10/18/2019
Registration date
11/17/2020
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/17/2020
Last transaction
11/18/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
09/01/2011
First use in commerce
09/01/2011
Drawing code
4
Owner type
16
Owner location
Ridgeland, MS
Examiner
FERRELL,STEVEN WAYNE
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Xspire Pharma, LLC
Representatives
Mindi M. Richter Shumaker, Loop & Kendrick, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of cardiovasculardermatologicalgastrointestinalneurologicalrespiratorypsychiatricallergicmetabolicmuscularinfectious and inflammatory conditions in humansnone of the foregoing to include preparations and substances for the treatment of oral lesionscutssores and blisters
Publications
History of USPTO decisions and trademark events.
17 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/17/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/27/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/27/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/27/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/01/2020
PUBO
PUBLISHED FOR OPPOSITION
09/01/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/12/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/28/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/23/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/23/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/23/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/24/2020
GNRT
NON-FINAL ACTION E-MAILED
01/24/2020
CNRT
NON-FINAL ACTION WRITTEN
01/24/2020
DOCK
ASSIGNED TO EXAMINER
01/24/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/22/2019
Continuous trademark protection
Get notified about every new filing that threatens XSPIRE PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.